Credit Agricole
CLVS

Credit Agricole’s Clovis Oncology, Inc. CLVS Stock Holding History

Credit Agricole’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,500
Closed -$1.61M – 1180
2017
Q3 		$1.61M Buy
19,500
+19,000
+3,800% +$1.51M 0.01% 971
2017
Q2 		$47K Buy
+500
New +$30.6K ﹤0.01% 1385
2016
Q2 		– Sell
-4,344
Closed -$83K – 1533
2016
Q1 		$83K Buy
+4,344
New +$91.9K ﹤0.01% 1192
2014
Q2 		– Sell
-2,300
Closed -$159K – 1677
2014
Q1 		$159K Buy
+2,300
New +$169K ﹤0.01% 1306

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Carmignac Gestion
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Credit Agricole's CLVS Position: Q4 2017 in Review

Credit Agricole sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 19,500 shares — an estimated $1.61M sold.

Credit Agricole first reported a position in CLVS in Q1 2014 and held it in 4 quarters. The position peaked at $1.61M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Credit Agricole reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Credit Agricole sold 19,500 Clovis Oncology, Inc. shares in Q4 2017, an estimated $1.61M.
  • Credit Agricole first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 4 quarters.
  • Credit Agricole's Clovis Oncology, Inc. position peaked at $1.61M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.